{"id":41664,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/transfer-rights-agreement-accenture-ltd.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"transfer-rights-agreement-accenture-ltd","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/formation\/transfer-rights-agreement-accenture-ltd.html","title":{"rendered":"Transfer Rights Agreement &#8211; Accenture Ltd."},"content":{"rendered":"<pre><hr align=\"center\" width=\"100%\" size=\"2\" noshade>\n<p align=\"right\"> <\/p>\n<p align=\"CENTER\"><font size=\"2\">TRANSFER RIGHTS AGREEMENT\n<br>\n\n<br>\n\n<br>\n\n<br>\nAMONG\n<br>\n\n<br>\n\n<br>\n\n<br>\nACCENTURE SCA\n<br>\n\n<br>\n\n<br>\n\n<br>\nand\n<br>\n\n<br>\n\n<br>\n\n<br>\nTHE COVERED PERSONS SIGNATORY HERETO\n<br>\n\n<br>\n\n<br>\n\n<br>\nDated as of April 18, 2001<\/font><\/p>\n<hr align=\"center\" width=\"100%\" size=\"2\" noshade> \n<p><\/p>\n<\/pre>\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"0\" width=\"600\">\n<tr valign=\"BOTTOM\">\n<td colspan=\"3\" align=\"LEFT\">\n<div align=\"center\"><font size=\"2\">TABLE OF CONTENTS<\/font><\/div>\n<\/td>\n<td width=\"2%\" align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td width=\"94%\" align=\"LEFT\"> <\/td>\n<td colspan=\"2\" align=\"LEFT\"> <\/td>\n<td width=\"2%\" align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td width=\"94%\" align=\"LEFT\"> <\/td>\n<td colspan=\"2\" align=\"LEFT\">\n<div align=\"right\"><font size=\"2\"> <u>Page<\/u><\/font><\/div>\n<\/td>\n<td width=\"2%\" align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td width=\"94%\" align=\"LEFT\"><\/td>\n<td width=\"2%\" align=\"LEFT\"><\/td>\n<td width=\"2%\" align=\"RIGHT\"><\/td>\n<td width=\"2%\" align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td width=\"94%\" align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1051\">ARTICLE I DEFINITIONS AND OTHER MATTERS<\/a><br \/>\n<\/font><\/td>\n<td width=\"2%\" align=\"LEFT\"><\/td>\n<td width=\"2%\" align=\"RIGHT\"><font size=\"2\">1<\/font><\/td>\n<td width=\"2%\" align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1051a\">Section 1.1. Definitions<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">1<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1054\">Section 1.2.  Gender<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">4<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"> <\/td>\n<td align=\"LEFT\"> <\/td>\n<td> <\/td>\n<td><\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1055\">ARTICLE II LIMITATIONS ON TRANSFER OF SHARES<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td>\n<div align=\"right\"><font size=\"2\">5<\/font><\/div>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1055a\">Section 2.1.\u00a0\u00a0 Transfer Restrictions<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">5<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1055b\">Section 2.2.\u00a0\u00a0 Release of Transfer Restrictions<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">5<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1058\">Section 2.3.\u00a0\u00a0 Certain Additional Restrictions<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">8<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex1058a\">Section 2.4.\u00a0\u00a0 Holding of Covered Shares in Custody and\/or in Nominee Name; Legend on Certificates; Entry of Stop Transfer Orders<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">8<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td><\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"> <\/td>\n<td align=\"LEFT\"> <\/td>\n<td> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10510\">ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE PARTIES<\/a><br \/>\n <\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td>\n<div align=\"right\"><font size=\"2\">10<\/font><\/div>\n<\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10511\">ARTICLE IV OTHER AGREEMENTS OF THE PARTIES<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">11<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10511a\">Section 4.1.\u00a0\u00a0 Redemption Price<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">11<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10511b\">Section 4.2.\u00a0\u00a0 Accenture SCA Partners Committee<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">11<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10512\">Section 4.3.\u00a0\u00a0 Indemnification and Expenses<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">12<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10513\">Section 4.4.\u00a0\u00a0 Adjustment upon Changes in Capitalization; Adjustments upon Changes of Control; Representatives, Successors and Assigns<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">13<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10514\">Section 4.5.\u00a0\u00a0 Filing of Schedule 13D or 13G<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">14<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10515\">Section 4.6.\u00a0\u00a0 Further Assurances<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">15<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10515a\">ARTICLE V MISCELLANEOUS<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">15<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"> <\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10515b\">Section 5.1.\u00a0\u00a0 Term of the Agreement; Termination of Certain Provisions<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">15<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10515c\">Section 5.2.\u00a0\u00a0 Amendments<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">15<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10516\">Section 5.3.\u00a0\u00a0 Waivers<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">16<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10517\">Section 5.4.\u00a0\u00a0 Governing Law<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">17<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10517a\">Section 5.5.\u00a0\u00a0 Resolution of Disputes<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">17<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10519\">Section 5.6.\u00a0\u00a0 Relationship of Parties<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">19<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10519a\">Section 5.7.\u00a0\u00a0 Notices<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">19<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10520\">Section 5.8.\u00a0\u00a0 Severability<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">20<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10520a\">Section 5.9.\u00a0\u00a0 Right to Determine Tender Confidentially<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">20<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10520b\">Section 5.10.\u00a0\u00a0 No Third-Party Rights<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">20<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10520c\">Section 5.11.\u00a0\u00a0 Section Headings<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">20<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10520d\">Section 5.12.\u00a0\u00a0 Execution in Counterparts<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><font size=\"2\">20<\/font><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<tr valign=\"BOTTOM\">\n<td align=\"LEFT\"><font size=\"2\"><br \/>\n<a href=\"#486ex10523\">Appendix A &#8211; Covered Persons<\/a><br \/>\n<\/font><\/td>\n<td align=\"LEFT\"><\/td>\n<td align=\"RIGHT\"><\/td>\n<td align=\"LEFT\"> <\/td>\n<\/tr>\n<\/table>\n<p><font size=\"2\"><br \/>\n<a href=\"#P124_27314\"> <\/a><\/p>\n<p><a href=\"#P136_31215\"> <\/a><\/p>\n<p><a href=\"#P211_59760\"> <\/a><br \/>\n<\/font><\/p>\n<p><font size=\"2\">     This Transfer Rights Agreement, dated as of April 18, 2001 (as amended, supplemented, waived or otherwise modified from time to time in accordance with its terms,<br \/>\nthis \u0093Agreement\u0094), among Accenture SCA, a Luxembourg <i>soci\u00e9t\u00e9 en commandite par actions<\/i> (\u0093Accenture SCA\u0094), and the Covered Persons (hereinafter defined).<\/font><\/p>\n<p align=\"CENTER\"><font size=\"2\">WITNESSETH:<\/font><\/p>\n<p><font size=\"2\">     WHEREAS, the Covered Persons may in the future become beneficial owners of Class I Common Shares, par value 1.25 euro per share, of Accenture SCA (the \u0093Common<br \/>\nShares\u0094).<\/font><\/p>\n<p><font size=\"2\">     WHEREAS, the Covered Persons desire to address herein certain relationships among themselves with respect to the disposition of their Common Shares and various<br \/>\nother matters and desire to give to the Accenture SCA Partners Committee (hereinafter defined) the power to enforce their agreements with respect thereto on their behalf.<\/font><\/p>\n<p><font size=\"2\">     NOW, THEREFORE, in consideration of the premises and of the mutual agreements, covenants and provisions herein contained, the parties hereto agree as<br \/>\nfollows:<\/font><\/p>\n<p align=\"CENTER\"><font size=\"2\"><br \/>\n<a name=\"486ex1051\"><\/a><br \/>\nARTICLE I<br \/>\n<a name=\"P51_2498\"><br \/>\n<br \/>\n<\/a><br \/>\nDEFINITIONS AND OTHER MATTERS<br \/>\n<a name=\"P51_2527\"><\/a><br \/>\n<\/font><\/p>\n<p align=\"left\"><font size=\"2\"><br \/>\n<a name=\"486ex1051a\"><\/a><br \/>\nSection 1.1. <u>Definitions<\/u>. The following words and phrases as used herein shall have the following meanings, except as otherwise expressly provided or unless the context otherwise requires: <\/font><\/p>\n<p><font size=\"2\">     (a) \u0093Accenture Ltd Class A Common Shares\u0094 shall mean the Class A Common Shares of Accenture LTD, an exempted company limited by shares organized under the<br \/>\nlaws of Bermuda.<\/font><\/p>\n<p><font size=\"2\">     (b) \u0093Accenture SCA\u0094 shall have the meaning ascribed to such term in the preamble hereto.<\/font><\/p>\n<p><font size=\"2\">     (c) \u0093Accenture SCA Partners Committee\u0094 shall have the meaning ascribed to such term in Section 4.2 hereof.<\/font><\/p>\n<p><font size=\"2\">     (d) This \u0093Agreement\u0094 shall have the meaning ascribed to such term in the preamble hereto.<\/font><\/p>\n<p><font size=\"2\">     (e) \u0093Base Eligible Sales\u0094 shall have the meaning ascribed to such term in Section 2.2 hereof.<\/font><\/p>\n<p><font size=\"2\">     (f) A \u0093beneficial owner\u0094 of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or<br \/>\notherwise has, or shares: (i) voting power, which includes the power to vote, or to direct the voting of, such security and\/or (ii) investment power, which includes the power to dispose, or to direct the disposition of, such security, but for<br \/>\npurposes of this Agreement a person shall not be deemed a beneficial owner of Common Shares (A) solely by virtue of the application of Exchange Act Rule 13d-3(d) or Exchange Act Rule 13d-5 as in effect on the date hereof, (B) solely by virtue of the<br \/>\npossession of the legal right to vote securities under applicable law (such as by proxy, power of attorney or appointment as corporate representative) or (C) held of record by a \u0093private foundation\u0094 subject to the requirements of Section<br \/>\n509 of the Code (or equivalent in other jurisdictions as determined from time to time by the Accenture SCA Partners Committee). \u0093Beneficially own\u0094 and \u0093beneficial ownership\u0094 shall have correlative meanings. For purposes of the<br \/>\ndetermination of beneficial ownership only, the provisions of Article II hereof shall not be deemed to transfer the investment power with respect to any Common Shares. <\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (g) \u0093Code\u0094 shall mean the United States Internal Revenue Code of 1986, as amended from time to time, and the applicable rulings and regulations<br \/>\nthereunder. <\/font><\/p>\n<p><font size=\"2\">     (h) \u0093Common Shares\u0094 shall have the meaning ascribed to such term in the recitals hereto.<\/font><\/p>\n<p><font size=\"2\">     (i) \u0093Company\u0094 shall mean Accenture SCA, together with its general partner and its Subsidiaries from time to time.<\/font><\/p>\n<p><font size=\"2\">     (j) \u0093Continuing Provisions\u0094 shall have the meaning ascribed to such term in Section 5.1(b) hereof. <\/font><\/p>\n<p><font size=\"2\">     (k) \u0093Covered Persons\u0094 shall mean those persons, other than Accenture SCA, who are from time to time parties to this Agreement and whose names are, or are<br \/>\nrequired to be, listed on Appendix A hereto, in each case in accordance with the terms hereof.<\/font><\/p>\n<p><font size=\"2\">     (l) A Covered Person\u0092s \u0093Covered Shares\u0094 shall mean any Common Shares beneficially owned by such Covered Person at the time in question but, shall not<br \/>\ninclude any Common Shares excluded from the definition of Covered Shares by action of the Accenture SCA Partners Committee prior to the IPO Date. \u0093Covered Shares\u0094 shall also include the securities that are defined to be \u0093Covered<br \/>\nShares\u0094 in Section 4.4 hereof. A Covered Person \u0093acquires\u0094 Covered Shares when such Covered Person first acquires beneficial ownership over such Covered Shares.<\/font><\/p>\n<p><font size=\"2\">     (m) The term \u0093disabled\u0094 shall mean \u0093disabled\u0094 as defined (i) in any employment agreement then in effect between the employee and the Company, or<br \/>\n(ii) if not defined therein, or if there shall be no such agreement, as defined in the Company\u0092s long-term disability plan as in effect from time to time, or (iii) if there shall be no plan, the inability of an employee to perform in all<br \/>\nmaterial respects his duties and responsibilities to the Company for a period of six (6) consecutive months or for an aggregate of nine (9) months in any twenty-four (24) consecutive month period by reason of a physical or mental incapacity. Any<br \/>\nquestion as to the existence of a disability as to which the employee and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to the employee and the Company. If the employee and the<br \/>\nCompany cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall make such determinations in writing. The determination of disability made in writing to the<br \/>\nCompany and the employee shall be final and conclusive for all purposes of this Agreement.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (n) \u0093Disabled Employee\u0094 shall have the meaning ascribed to such term in Section 2.2 hereof.<\/font><\/p>\n<p><font size=\"2\">     (o) An \u0093employee\u0094 shall include, without limitation, the owners and employees of partner personal service companies in certain countries with which the<br \/>\nCompany has personal service contracts (in each case as agreed by the Accenture SCA Partners Committee), and any other similarly situated person designated as an \u0093employee\u0094 by the Accenture SCA Partners Committee.<\/font><\/p>\n<p><font size=\"2\">     (p) \u0093Employee Covered Person\u0094 shall mean a Covered Person that is an employee of the Company at the time in question, provided that if the Company has<br \/>\nreceived notice that any Covered Person intends to terminate such Covered Person\u0092s employment with the Company (except in the case of notice with respect to retirement or disability), such Covered Person shall be deemed not to be an Employee<br \/>\nCovered Person.<\/font><\/p>\n<p><font size=\"2\">     (q) \u0093Employee Covered Shares\u0094 shall have the meaning ascribed to such term in Section 5.1 hereof.<\/font><\/p>\n<p><font size=\"2\">     (r) \u0093Exchange Act\u0094 shall mean the United States Securities Exchange Act of 1934, as amended to date and as further amended from time to time.<\/font><\/p>\n<p><font size=\"2\">     (s) A reference to an \u0093Exchange Act Rule\u0094 shall mean such rule or regulation of the United States Securities and Exchange Commission under the Exchange<br \/>\nAct, as in effect from time to time or as replaced by a successor rule thereto.<\/font><\/p>\n<p><font size=\"2\">     (t) \u0093IPO Date\u0094 shall mean the closing date of the initial public offering of the Accenture Ltd Class A Common Shares.<\/font><\/p>\n<p><font size=\"2\">     (u) \u0093Market Price of an Accenture Ltd Class A Common Share\u0094 shall have the meaning ascribed to such term in the Articles of Association of Accenture SCA,<br \/>\nas such term may be amended from time to time pursuant to the Articles of Association of Accenture SCA.<\/font><\/p>\n<p><font size=\"2\">     (v) \u0093Non-Competition Agreement\u0094 shall mean, collectively, any Non-Competition Agreement, dated as of the date hereof, among the Company and the partners<br \/>\nfrom time to time party thereto.<\/font><\/p>\n<p><font size=\"2\">     (w) \u0093Permitted Basket Transaction\u0094 shall mean the purchase or sale of, or the establishment of a long or short position in, a basket or index of<br \/>\nsecurities (or of a derivative financial instrument with respect to a basket or index of securities) that includes securities of the Company, in each case if such purchase, sale or establishment is permitted under the Company\u0092s policy on<br \/>\nhedging with respect to securities of the Company and other relevant policies, including insider trading policies, as announced from time to time.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (x) A \u0093person\u0094 shall include, as applicable, any individual, estate, trust, corporation, partnership, limited liability company, unlimited liability<br \/>\ncompany, foundation, association or other entity.<\/font><\/p>\n<p><font size=\"2\">     (y) \u0093Retired Employee\u0094 shall have the meaning ascribed to such term in Section 2.2 hereof.<\/font><\/p>\n<p><font size=\"2\">     (z) \u0093Securities Act\u0094 shall mean the United States Securities Act of 1933, as amended from time to time.<\/font><\/p>\n<p><font size=\"2\">     (aa) \u0093Sole Beneficial Owner\u0094 shall mean a person who is the beneficial owner of Covered Shares, who does not share beneficial ownership of such Covered<br \/>\nShares with any other person (other than pursuant to this Agreement, the Non-Competition Agreement or applicable community property laws) and who is the only person (other than pursuant to applicable community property laws) with a direct economic<br \/>\ninterest in the Covered Shares. An economic interest of the Company (or of any other person with respect to which the Company has expressly agreed to in writing) as pledgee shall be disregarded for this purpose. A Covered Person that holds Covered<br \/>\nShares indirectly through a wholly-owned personal holding company shall be considered the \u0093Sole Beneficial Owner\u0094 of such Covered Shares, provided that such personal holding company is a Covered Person hereunder.<\/font><\/p>\n<p><font size=\"2\">     (bb) \u0093Subsidiary\u0094 shall mean any person in which Accenture SCA owns, directly or indirectly, at least a majority of the equity, economic or voting<br \/>\ninterest.<\/font><\/p>\n<p><font size=\"2\">     (cc) \u0093Transfer\u0094 shall mean any sale, transfer, pledge, hypothecation or other disposition, whether direct or indirect, whether or not for value, and shall<br \/>\ninclude any disposition of the economic or other risks of ownership of Covered Shares, including short sales of securities of the Company, option transactions (whether physical or cash settled) with respect to securities of the Company, use of<br \/>\nequity or other derivative financial instruments relating to securities of the Company and other hedging arrangements with respect to securities of the Company, in each such case other than Permitted Basket Transactions. <\/font><\/p>\n<p><font size=\"2\">     (dd) \u0093Transfer Restrictions\u0094 shall have the meaning ascribed to such term in Section 2.1 hereof.<\/font><\/p>\n<p><font size=\"2\">     (ee) \u0093Valuation Ratio\u0094 shall have the meaning ascribed to such term in the Articles of Association of Accenture SCA, as such ratio may be adjusted from<br \/>\ntime to time pursuant to the Articles of Association of Accenture SCA.<\/font><\/p>\n<p><font size=\"2\">     (ff) \u0093vote\u0094 shall include, without limitation, actions taken or proposed to be taken by written consent. <\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex1054\"><\/a><br \/>\nSection 1.2. <u>Gender<\/u>. For the purposes of this Agreement, the words \u0093he,\u0094 \u0093his\u0094 or \u0093himself\u0094 shall be interpreted to include the masculine, feminine and corporate, other entity or trust form.<\/font><\/p>\n<\/p>\n<p align=\"CENTER\"><font size=\"2\">ARTICLE II<br \/>\n<a name=\"486ex1055\"><br \/>\n<br \/>\n<\/a><br \/>\nLIMITATIONS ON TRANSFER OF SHARES<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex1055a\"><\/a><br \/>\nSection 2.1.\u00a0\u00a0 <u>Transfer Restrictions<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) Each Covered Person agrees for the benefit of every other Covered Person that such Covered Person shall at all times be the Sole Beneficial Owner of all Covered<br \/>\nShares beneficially owned by such Covered Person as of or prior to the IPO Date (such requirements with respect to ownership of Covered Shares, collectively, the \u0093Transfer Restrictions\u0094). <\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex1055b\"><\/a><br \/>\nSection 2.2.\u00a0\u00a0 <u>Release of Transfer Restrictions<\/u><\/font><\/p>\n<p><font size=\"2\">     (a) Notwithstanding Section 2.1, an Employee Covered Person may:<\/font><\/p>\n<blockquote>\n<p><font size=\"2\">     (i) commencing on the date that is one year after the IPO Date, Transfer up to 10% of the aggregate number of Common Shares beneficially owned by such Employee<br \/>\nCovered Person as of the IPO Date;<\/font> <\/p>\n<p><font size=\"2\">     (ii) commencing on the date that is two years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of<br \/>\nup to 25% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date;<\/font> <\/p>\n<p><font size=\"2\">     (iii) commencing on the date that is three years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a))<br \/>\nof up to 35% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date;<\/font> <\/p>\n<p><font size=\"2\">     (iv) commencing on the date that is four years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of<br \/>\nup to 45% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date;<\/font> <\/p>\n<p><font size=\"2\">     (v) commencing on the date that is five years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of<br \/>\nup to 55% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date;<\/font> <\/p>\n<p><font size=\"2\">     (vi) commencing on the date that is six years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of<br \/>\nup to 65% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date; and<\/font> <\/p>\n<p><font size=\"2\">     (vii) commencing on the date that is seven years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a))<br \/>\nof up to 75% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date.<\/font> <\/p>\n<\/blockquote>\n<p><font size=\"2\">       (b) Notwithstanding Section 2.1, a Covered Person may Transfer any Common Shares beneficially owned by such Covered Person as of the IPO Date commencing<br \/>\non the later of (i) the date that is eight years after the IPO Date and (ii) the date that such Covered Person ceases to be an employee of the Company.<\/font><\/p>\n<p><font size=\"2\">       (c) Notwithstanding Section 2.1, an Employee Covered Person that retires at the age of 50 or older and is not in contravention of the Non-Competition<br \/>\nAgreement (a \u0093Retired Employee\u0094) may, following the first anniversary of the IPO Date:<\/font><\/p>\n<blockquote>\n<p><font size=\"2\">     (i) if such Retired Employee retires at age 50, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is<br \/>\nequal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of Common Shares eligible for sale at the date of such retirement<br \/>\npursuant to paragraph (a) of Section 2.2 (the \u0093Base Eligible Sales\u0094) and (b) the product of (A) (1 minus Base Eligible Sales) multiplied by (B) 0.25; <\/font> <\/p>\n<p><font size=\"2\">     (ii) if such Retired Employee retires at age 51, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is<br \/>\nequal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base<br \/>\nEligible Sales) multiplied by (B) 0.375; <\/font> <\/p>\n<p><font size=\"2\">     (iii) if such Retired Employee retires at age 52, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which<br \/>\nis equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base<br \/>\nEligible Sales) multiplied by (B) 0.50; <\/font> <\/p>\n<p><font size=\"2\">     (iv) if such Retired Employee retires at age 53, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is<br \/>\nequal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base<br \/>\nEligible Sales) multiplied by (B) 0.625; <\/font> <\/p>\n<p><font size=\"2\">     (v) if such Retired Employee retires at age 54, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is<br \/>\nequal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base<br \/>\nEligible Sales) multiplied by (B) 0.75; <\/font><\/p>\n<p><font size=\"2\"> <\/font><\/p>\n<blockquote>\n<p><font size=\"2\">     (vi) if such Retired Employee retires at age 55, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is<br \/>\nequal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base<br \/>\nEligible Sales) multiplied by (B) 0.875; and <\/font> <\/p>\n<p><font size=\"2\">     (vii) if such Retired Employee retires at age 56 or above, Transfer 100% of the Common Shares beneficially owned by such Retired Employee as of the IPO Date.<\/font>\n<\/p>\n<\/blockquote>\n<p><font size=\"2\">     A Retired Employee may also Transfer the Common Shares beneficially owned by such Retired Employee as of the IPO Date in accordance with paragraph (a) of this<br \/>\nSection 2.2 as if such Retired Employee were an Employee Covered Person.<\/font><\/p>\n<p><font size=\"2\">     Following the first anniversary of the IPO Date, a Retired Employee that reaches the age of 56 may also Transfer 100% of the Common Shares beneficially owned by<br \/>\nsuch Retired Employee as of the IPO Date.<\/font><\/p>\n<p><font size=\"2\">     (d) Notwithstanding Section 2.1, a Covered Person that becomes disabled while an employee of the Company (a \u0093Disabled Employee\u0094) prior to May 31, 2001 (or<br \/>\nsuch other date that the Accenture SCA Partners Committee shall declare to be the date of the consummation of the Company\u0092s transition to a corporate structure), may Transfer 100% of Common Shares beneficially owned by such Disabled Employee as<br \/>\nof the IPO Date, following the first anniversary of the IPO Date. A Covered Person that becomes a Disabled Employee following May 31, 2001 (or such other date that the Accenture SCA Partners Committee shall declare to be the date of the consummation<br \/>\nof the Company\u0092s transition to a corporate structure) may (i) if such Disabled Employee becomes disabled prior to reaching the age of 50, Transfer Common Shares beneficially owned by such Disabled Employee as of the IPO Date in accordance with<br \/>\nthe provisions of paragraph (a) of this Section 2.2 as if such Disabled Employee were an Employee Covered Person and (ii) if such Disabled Employee becomes disabled after reaching the age of 50, Transfer Common Shares beneficially owned by such<br \/>\nDisabled Employee as of the IPO Date in accordance with the provisions of paragraph (c) of this Section 2.2 as if such Disabled Employee were a Retired Employee.<\/font><\/p>\n<p><font size=\"2\">     (e) Notwithstanding Section 2.1, a Covered Person may Transfer Common Shares beneficially owned by such Covered Person as of the IPO Date pursuant to bona fide<br \/>\npledges of Common Shares approved by Accenture SCA in writing and any foreclosures thereunder, provided that the pledgee has agreed in writing with Accenture SCA (any such agreement to be satisfactory to Accenture SCA in its sole discretion) that<br \/>\nAccenture SCA shall have a right of first refusal to purchase such Common Shares at the market price prior to any sale of such Common Shares by such pledgee.<\/font><\/p>\n<p><font size=\"2\">     (f) Notwithstanding Section 2.1, commencing on the third anniversary of May 31, 2001 (or such other date that the Accenture SCA Partners Committee shall declare to<br \/>\nbe the date of the consummation of the Company\u0092s transition to a corporate structure), the Common Shares are redeemable at the option of the Covered Person for a redemption price per share equal to the lower of (i) the Valuation Ratio<br \/>\nmultiplied by the Market Price of an Accenture Ltd Class A Common Share and (ii) one United States dollar.<\/font><\/p>\n<\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex1058\"><\/a><br \/>\nSection 2.3.\u00a0\u00a0 <u>Certain Additional Restrictions<\/u>.<\/font><\/p>\n<p><font size=\"2\">     Each Covered Person agrees for the benefit of every other Covered Person that for so long as such Covered Person is an Employee Covered Person, such Covered Person<br \/>\nwill comply with any restrictions on Transfer relating to Common Shares imposed by the Company and notified to such Covered Person from time to time to enable the Company or any party to an agreement with the Company to (i) account for a business<br \/>\ncombination by the pooling of interests method or (ii) pursuant to the Company\u0092s insider trading policies from time to time.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex1058a\"><\/a><br \/>\nSection 2.4.\u00a0\u00a0<u>Holding of Covered Shares in Custody and\/or in Nominee Name; Legend on Certificates; Entry of Stop Transfer Orders<\/u>. <\/font><\/p>\n<p><font size=\"2\">     (a) Each Covered Person understands and agrees that all Covered Shares beneficially owned by such Covered Person (in each case other than Covered Shares held of<br \/>\nrecord by a trustee in a compensation or benefit plan administered by the Company and other Covered Shares that have been pledged to the Company (or to a third party agreed to in writing by the Company) to secure the performance of such Covered<br \/>\nPerson\u0092s obligations under any agreement with the Company (or with any other person with respect to which the Company has expressly agreed to in writing)) shall, at the sole discretion of the Accenture SCA Partners Committee, be registered in<br \/>\nthe name of a nominee for such Covered Person and\/or shall be held in the custody of a custodian until otherwise determined by the Accenture SCA Partners Committee or until such time as such Covered Shares are released pursuant to paragraphs (e) or<br \/>\n(f) of this Section 2.4 and, by his signature hereto, each Covered Person appoints the Accenture SCA Partners Committee, and each member thereof individually, with full power of substitution and resubstitution, his true and lawful attorney-in-fact<br \/>\nto assign, endorse and register for transfer into such nominee\u0092s name or deliver to such custodian any such Covered Shares which are not so registered or so held, as the case may be, and to enter into any custody agreement with respect to such<br \/>\nCovered Shares, granting to such attorneys, and each of them, full power and authority to do and perform each and every act and thing whatsoever that such attorney or attorneys may deem necessary, advisable or appropriate to carry out fully the<br \/>\nintent of this paragraph (a) of this Section 2.4 as such Covered Person might or could do personally, hereby ratifying and confirming all acts and things that such attorney or attorneys may do or cause to be done by virtue of this power of attorney.<br \/>\nIt is understood and agreed by each such Covered Person that this appointment, empowerment and authorization may be exercised by the aforementioned persons with respect to all Covered Shares of such Covered Person, and held of record by another<br \/>\nperson, for the period beginning on the date hereof and ending on the date this Agreement shall have been terminated pursuant to Section 5.1(a) hereof. The form of the custody agreement and the identity of the custodian and\/or nominee shall be as<br \/>\ndetermined by the Accenture SCA Partners Committee from time to time.<\/font><\/p>\n<p><font size=\"2\">     (b) Whenever any nominee holder shall receive any dividend or other distribution in respect of any Covered Shares, satisfied otherwise than in Covered Shares, the<br \/>\nAccenture SCA Partners Committee will give or cause to be given notice or direction to the applicable nominee and\/or custodian referred to in paragraph (a) to permit the prompt distribution of such dividend or distribution to the beneficial owner of<br \/>\nsuch Covered Shares, net of any tax withholding amounts required to be withheld by the nominee, unless the distribution of such dividend or distribution is restricted by the terms of another agreement between the Covered Person and the Company (or<br \/>\nwith any other person with respect to which the Company has expressly agreed in writing) known to the Accenture SCA Partners Committee.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (c) Each Covered Person understands and agrees that any share certificate representing Covered Shares beneficially owned by such Covered Person, and any agreement<br \/>\nor other instrument evidencing restricted share units, options or other rights to receive or acquire Covered Shares beneficially owned by such Covered Person, may bear a legend noted conspicuously on each such certificate, agreement or other<br \/>\ninstrument reading substantially as follows: <\/font><\/p>\n<ul>\n<p><font size=\"2\">\u0093THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE PROVISIONS OF A TRANSFER RIGHTS AGREEMENT AMONG ACCENTURE SCA AND THE PERSONS NAMED THEREIN, A COPY OF WHICH IS ON FILE AT<br \/>\nTHE PRINCIPAL OFFICE OF ACCENTURE SCA AND WHICH, AMONG OTHER MATTERS, PLACES RESTRICTIONS ON THE DISPOSITION OF SUCH SECURITIES. THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE SOLD, EXCHANGED, TRANSFERRED, ASSIGNED, PLEDGED, PARTICIPATED,<br \/>\nHYPOTHECATED OR OTHERWISE DISPOSED OF ONLY IN ACCORDANCE THEREWITH.\u0094<\/font><\/p>\n<\/ul>\n<p><font size=\"2\">     (d) Each Covered Person agrees and consents (i) that the Board of Directors may refuse to register the transfer of and (ii) to the entry of stop transfer orders<br \/>\nagainst the transfer of Covered Shares subject to Transfer Restrictions except in compliance with this Agreement. <\/font><\/p>\n<p><font size=\"2\">     (e) All Covered Shares of each Covered Person who is not an Employee Covered Person which could then be Transferred without contravening any Transfer Restrictions<br \/>\nshall be released, pursuant to procedures to be developed by the Accenture SCA Partners Committee, to or at the direction of such Covered Person free and clear of all restrictions and legends described in this Section 2.4.<\/font><\/p>\n<p><font size=\"2\">     (f) A specified number of Covered Shares of an Employee Covered Person shall be released, pursuant to procedures to be developed by the Accenture SCA Partners<br \/>\nCommittee, upon the request of such Employee Covered Person and to or at the direction of such Employee Covered Person (free and clear of all restrictions and legends described in this Section 2.4), provided that such request is accompanied by a<br \/>\ncertificate of such requesting Employee Covered Person (i) indicating such requesting Employee Covered Person\u0092s intention to Transfer promptly such specified number of Covered Shares and (ii) establishing that such specified number of Covered<br \/>\nShares are then permitted to be Transferred without contravening any Transfer Restrictions (which evidence must be satisfactory to the Accenture SCA Partners Committee).<\/font><\/p>\n<\/p>\n<p align=\"CENTER\"><font size=\"2\">ARTICLE III<br \/>\n<a name=\"486ex10510\"><br \/>\n<br \/>\n<\/a><br \/>\nREPRESENTATIONS AND WARRANTIES OF THE PARTIES<\/font><\/p>\n<p><font size=\"2\">        Each Covered Person severally represents and warrants that: <\/font><\/p>\n<blockquote>\n<p><font size=\"2\">     (i) such Covered Person has (and with respect to Covered Shares to be acquired in the future, will have) good, valid and marketable title to the Covered Shares,<br \/>\nfree and clear of any pledge, lien, security interest, charge, claim, equity or encumbrance of any kind, other than pursuant to this Agreement, another agreement with the Company, or any other agreement with another person with respect to which the<br \/>\nCompany has expressly agreed to in writing, by which such Covered Person is bound and to which the Covered Shares are subject; <\/font> <\/p>\n<p><font size=\"2\">     (ii) this Agreement constitutes the legal, valid and binding obligation of such Covered Person, enforceable against such Covered Person in accordance with its terms<br \/>\n(subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors\u0092 rights generally and to general equitable principles (whether considered in a<br \/>\nproceeding in equity or at law)); <\/font> <\/p>\n<p><font size=\"2\">     (iii) there are no actions, suits or proceedings pending, or, to the knowledge of such Covered Person, threatened against or affecting such Covered Person or such<br \/>\nCovered Person\u0092s assets in any court or before or by any federal, state, municipal or other domestic or foreign governmental department, commission, board, bureau, agency or instrumentality which, if adversely determined, would impair the<br \/>\nability of such Covered Person to perform or comply with this Agreement; <\/font> <\/p>\n<p><font size=\"2\">     (iv) such Covered Person understands that his ability to transfer the Covered Shares is subject to legal and contractual restrictions and that the Covered Shares<br \/>\nhave not been registered under the United States Securities Act of 1933, and that he is holding the Covered Shares for his own account, for investment, and not for distribution, assignment or resale to others, and no other person has any direct or<br \/>\nindirect beneficial interest in such shares (other than the Company or at the express written consent of the Company); and <\/font> <\/p>\n<p><font size=\"2\">     (v) no statement, representation or warranty made by such Covered Person in this Agreement, nor any information provided by such Covered Person for inclusion in a<br \/>\nreport filed pursuant to Section 4.5 hereof or in a registration statement filed by the Company contains or will contain any untrue statement of a material fact or omits or will omit to state a material fact necessary in order to make the<br \/>\nstatements, representations or warranties contained herein or information provided therein not misleading.<\/font> <\/p>\n<\/blockquote>\n<p><font size=\"2\">        Each Covered Person that is not a natural person additionally and severally represents and warrants that:<\/font><\/p>\n<\/p>\n<blockquote>\n<p><font size=\"2\">     (i) such Covered Person is duly organized and validly existing in good standing under the laws of the jurisdiction of such Covered Person\u0092s formation; <\/font>\n<\/p>\n<p><font size=\"2\">     (ii) such Covered Person has full right, power and authority to enter into and perform this Agreement; and<\/font> <\/p>\n<p><font size=\"2\">     (iii) the execution and delivery of this Agreement and the performance of the transactions contemplated herein have been duly authorized, and no further proceedings<br \/>\non the part of such Covered Person are necessary to authorize the execution, delivery and performance of this Agreement; and this Agreement has been duly executed by such Covered Person.<\/font> <\/p>\n<\/blockquote>\n<p><font size=\"2\">        Each Covered Person severally agrees that the foregoing provisions of this Article III shall be continuing representations and warranties of such<br \/>\nCovered Person during the period that such person shall be a Covered Person and Common Shares of such person shall be Covered Shares, and such Covered Person shall take all actions as shall from time to time be necessary to cure any breach or<br \/>\nviolation and to obtain any authorizations, consents, approvals and clearances in order that such representations and warranties shall be true and correct during such period. <\/font><\/p>\n<p align=\"CENTER\"><font size=\"2\">ARTICLE IV<br \/>\n<a name=\"486ex10511\"><br \/>\n<br \/>\n<\/a><br \/>\nOTHER AGREEMENTS OF THE PARTIES<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10511a\"><\/a><br \/>\nSection 4.1.\u00a0\u00a0 <u>Redemption Price<\/u><\/font><\/p>\n<p><font size=\"2\">        Each Covered Person agrees that the redemption price payable in connection with any redemption of such Covered Person\u0092s Common Shares (i)<br \/>\nunder Article 7 of the Articles of Association of Accenture SCA, as such redemption price is calculated in accordance with such Article 7, or (ii) under paragraph (f) of Section 2.2 hereof, as such redemption price is calculated in accordance with<br \/>\nSection 2.2 hereof, may, at the option of Accenture SCA, be paid in cash or in Accenture Ltd Class A Common Shares.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10511b\"><\/a><br \/>\nSection 4.2.\u00a0\u00a0 <u>Accenture SCA Partners Committee.<\/u><\/font><\/p>\n<p><font size=\"2\">        (a) The \u0093Accenture SCA Partners Committee\u0094, as of any time, shall consist of the members of the Supervisory Board of Accenture SCA who<br \/>\nare also employees of the Company that hold the \u0093Partner\u0094 title and who agree to serve as members of the Accenture SCA Partners Committee. If there are less than three individuals who are both Partners and members of the Supervisory Board<br \/>\nof Accenture SCA and who agree to serve as members of the Accenture SCA Partners Committee, the Accenture SCA Partners Committee shall consist of each such individual plus such additional individuals who are Partners and who are selected pursuant to<br \/>\nprocedures established by the Accenture SCA Partners Committee as shall ensure that the Accenture SCA Partners Committee contains not less than three members who are Partners. The members of the Accenture SCA Partners Committee from time to time<br \/>\nwill be party to this Agreement in their capacities both as Covered Persons and as members of the Accenture SCA Partners Committee. Any member of the Accenture SCA Partners Committee that is not a Covered Person hereunder shall be deemed to be a<br \/>\nparty hereto solely in their capacity as a member of the Accenture SCA Partners Committee.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (b) (i) Except as otherwise provided herein, all determinations necessary or advisable under this Agreement (including determinations of beneficial ownership) shall<br \/>\nbe made by the Accenture SCA Partners Committee, whose determinations shall be final and binding. The Accenture SCA Partners Committee\u0092s determinations under this Agreement and actions (including waivers) hereunder need not be uniform and may<br \/>\nbe made selectively among Covered Persons (whether or not such Covered Persons are similarly situated).<\/font><\/p>\n<p><font size=\"2\">     (ii) Each Covered Person recognizes and agrees that each of the members of the Accenture SCA Partners Committee in acting hereunder shall at all times be acting in<br \/>\ntheir individual capacities and not as directors or officers of the Company and in so acting or failing to act shall not have any fiduciary duties to the Company or the Covered Persons as a member of the Accenture SCA Partners Committee by virtue of<br \/>\nthe fact that one or more of such members may also be serving as a director or officer of the Company or otherwise. Each Covered Person consequently recognizes that for a member of the Accenture SCA Partners Committee to also serve as a director or<br \/>\nofficer of the Company does not constitute a conflict.<\/font><\/p>\n<p><font size=\"2\">     (iii) The Accenture SCA Partners Committee shall act through a majority vote of its members. Such actions may be taken in person at a meeting or by a written<br \/>\ninstrument signed by all of the members. Meetings of the Accenture SCA Partners Committee may be held by such telephonic or other electronic means as the Accenture SCA Partners Committee may from time to time approve and which permit all persons<br \/>\nparticipating in the meeting to communicate with each other simultaneously and instantaneously and participation in such a meeting shall constitute presence in person at such a meeting.<\/font><\/p>\n<p><font size=\"2\">     (c) To the extent not addressed herein, actions to be taken pursuant to this Agreement shall be governed by procedures to be developed by the Accenture SCA Partners<br \/>\nCommittee.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10512\"><\/a><br \/>\nSection 4.3.\u00a0\u00a0 <u>Indemnification and Expenses<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) Accenture SCA agrees that it will indemnify and hold harmless each member of the Accenture SCA Partners Committee against any judgments, fines, losses, claims,<br \/>\ndamages or liabilities incurred by them in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of matters that pertain to this Agreement or the transactions<br \/>\ncontemplated hereby. Accenture SCA need not indemnify any member of the Accenture SCA Partners Committee against any judgments, fines, losses, claims, damages or liabilities incurred by the Accenture SCA Partners Committee through the Accenture SCA<br \/>\nPartners Committee\u0092s own gross negligence, bad faith or willful misconduct.<\/font><\/p>\n<p><font size=\"2\">     (b) Accenture SCA shall be responsible for all expenses of the Accenture SCA Partners Committee incurred in the operation and administration of this Agreement,<br \/>\nincluding expenses incurred in preparing appropriate filings and correspondence with the United States Securities and Exchange Commission or other securities regulators, lawyers\u0092, accountants\u0092, agents\u0092, consultants\u0092,<br \/>\nexperts\u0092, investment banking and other professionals\u0092 fees, expenses incurred in enforcing the provisions of this Agreement, expenses incurred in maintaining any necessary or appropriate books and records relating to this Agreement and<br \/>\nexpenses incurred in the preparation of amendments to and waivers of provisions of this Agreement.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (c) Each Covered Person shall be responsible for all expenses of such Covered Person incurred in connection with the compliance by such Covered Person with his<br \/>\nobligations under this Agreement, including expenses incurred by the Accenture SCA Partners Committee or Accenture SCA in enforcing the provisions of this Agreement relating to such obligations.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10513\"><\/a><br \/>\nSection 4.4.\u00a0\u00a0 <u>Adjustment upon Changes in Capitalization; Adjustments upon Changes of Control; Representatives, Successors and Assigns<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) In the event of any change in the outstanding Common Shares by reason of stock dividends, stock splits, reverse stock splits, spin-offs, split-ups,<br \/>\nrecapitalizations, combinations, exchanges of shares and the like, the term \u0093Covered Shares\u0094 shall refer to and include the securities received or resulting therefrom, but only to the extent such securities are received in exchange for or<br \/>\nin respect of Covered Shares. Upon the occurrence of any event described in the immediately preceding sentence, the Accenture SCA Partners Committee shall make such adjustments to or interpretations of the provisions of Sections 2.1, 2.2 and 4.1<br \/>\n(and, if they so determine, any other provisions hereof) as they shall deem necessary or desirable to carry out the intent of such provision(s). If the Accenture SCA Partners Committee deems it desirable, any such adjustments may take effect from<br \/>\nthe record date, the \u0093when issued trading date\u0094, the \u0093ex dividend date\u0094 or another appropriate date. <\/font><\/p>\n<p><font size=\"2\">     (b) In the event of any business combination, amalgamation, restructuring, recapitalization or other extraordinary transaction directly or indirectly involving<br \/>\nAccenture SCA, its Subsidiaries or any of their respective securities or assets as a result of which the Covered Persons shall hold voting securities of an entity other than Accenture SCA, the Covered Persons agree that this Agreement shall also<br \/>\ncontinue in full force and effect with respect to such voting securities of such other entity formerly representing or distributed in respect of Covered Shares of Accenture SCA, and the terms \u0093Covered Shares,\u0094 \u0093Common Shares\u0094,<br \/>\n\u0093Employee Covered Shares,\u0094 and \u0093Accenture SCA\u0094 and \u0093Company,\u0094 shall refer to such voting securities formerly representing or distributed in respect of Covered Shares of Accenture SCA and such entity, respectively. Upon<br \/>\nthe occurrence of any event described in the immediately preceding sentence, the Accenture SCA Partners Committee shall make such adjustments to or interpretations of the restrictions of Section 2.1 (and, if it so determines, any other provisions<br \/>\nhereof) as they shall deem necessary or desirable to carry out the intent of such provision(s). If the Accenture SCA Partners Committee deems it desirable, any such adjustments may take effect from the record date or another appropriate<br \/>\ndate.<\/font><\/p>\n<p><font size=\"2\">     (c) In the event of any business combination, amalgamation, restructuring, recapitalization or other extraordinary transaction directly or indirectly involving the<br \/>\nCompany or any of its securities or assets as a result of which the holders of Accenture Ltd Class A Common Shares shall hold voting securities of a different entity, the Covered Persons agree that the term \u0093Accenture Ltd Class A Common<br \/>\nShares\u0094 shall refer to such voting securities formerly representing or distributed in respect of Accenture Ltd Class A Common Shares. Upon the occurrence of any event described in the immediately preceding sentence, the Accenture SCA Partners<br \/>\nCommittee shall make such adjustments to or interpretations of Section 2.2 or 4.1 (and, if it so determines, any other provisions hereof) as it shall deem necessary or desirable to carry out the intent of such provision(s). If the Accenture SCA<br \/>\nPartners Committee deems it desirable, any such adjustments may take effect from the record date or another appropriate date.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (d) This Agreement shall be binding upon and inure to the benefit of the respective legatees, legal representatives, successors and assigns of the Covered Persons<br \/>\n(and Accenture SCA in the event of a transaction described in Section 4.4(b) hereof); provided, however, that a Covered Person may not assign this Agreement or any of his rights or obligations hereunder without the prior written consent of Accenture<br \/>\nSCA, and any assignment without such consent by a Covered Person shall be void; and, provided, further, that no assignment of this Agreement by Accenture SCA or to a successor of Accenture SCA (by operation of law or otherwise) shall be valid unless<br \/>\nsuch assignment is made to a person which succeeds to the business of Accenture SCA substantially as an entirety.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10514\"><\/a><br \/>\nSection 4.5.\u00a0\u00a0 <u>Filing of Schedule 13D or 13G<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) In the event that a Covered Person is required to file a report of beneficial ownership on Schedule 13D or 13G with respect to the Common Shares beneficially<br \/>\nowned by him (for this purpose as determined by Exchange Act Rule 13d-3 and Exchange Act Rule 13d-5), such Covered Person agrees for the benefit of every other Covered Person that, unless otherwise directed by the Accenture SCA Partners Committee,<br \/>\nsuch Covered Person will not file a separate such report, but will file a report together with the other Covered Persons, containing the information required by the Exchange Act, and such Covered Person understands and agrees that such report shall<br \/>\nbe filed on his behalf by the Accenture SCA Partners Committee or any member or designee thereof. Such Covered Person shall cooperate fully with the other Covered Persons and the Accenture SCA Partners Committee to achieve the timely filing of any<br \/>\nsuch report and any amendments thereto as may be required, and such Covered Person agrees that any information concerning such Covered Person which such Covered Person furnishes in connection with the preparation and filing of such report will be<br \/>\ncomplete and accurate.<\/font><\/p>\n<p><font size=\"2\">     By his signature hereto, each Covered Person appoints the Accenture SCA Partners Committee and each member thereof from time to time individually, with full power<br \/>\nof substitution and resubstitution, his true and lawful attorney-in-fact to execute such reports and any and all amendments thereto and to file such reports with all exhibits thereto and other documents in connection therewith with the United States<br \/>\nSecurities and Exchange Commission and, if necessary, other regulators, granting to such attorneys, and each of them, full power and authority to do and perform each and every act and thing whatsoever that such attorney or attorneys may deem<br \/>\nnecessary, advisable or appropriate to carry out fully the intent of this Section 4.5 as such Covered Person might or could do personally, hereby ratifying and confirming all acts and things that such attorney or attorneys may do or cause to be done<br \/>\nby virtue of this power of attorney. Each Covered Person hereby further designates such attorneys as such Covered Person\u0092s agents authorized to receive notices and communications with respect to such reports and any amendments thereto. It is<br \/>\nunderstood and agreed by each such Covered Person that this appointment, empowerment and authorization may be exercised by the aforementioned persons for the period beginning on the date hereof and ending on the date such Covered Person is no longer<br \/>\nsubject to the provisions of this Agreement (and shall extend thereafter for such time as is required to reflect that such Covered Person is no longer a party to this Agreement). <\/font><\/p>\n<\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10515\"><\/a><br \/>\nSection 4.6. <u>Further Assurances<\/u>. Each Covered Person agrees for the benefit of every other Covered Person to execute such additional documents and take such further action as may be reasonably necessary to effect the provisions of this<br \/>\nAgreement.<\/font><\/p>\n<p align=\"CENTER\"><font size=\"2\">ARTICLE V<br \/>\n<a name=\"486ex10515a\"><br \/>\n<br \/>\n<\/a><br \/>\nMISCELLANEOUS<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10515b\"><\/a><br \/>\nSection 5.1.\u00a0\u00a0 <u>Term of the Agreement; Termination of Certain Provisions<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) The term of this Agreement shall continue until the first to occur of the date that is 50 years after the date hereof and the date this Agreement is terminated<br \/>\nby the affirmative vote of not less than 66 2\/3% of the votes represented by the Covered Shares beneficially owned by Employee Covered Persons (such Covered Shares at any such time, the \u0093Employee Covered Shares\u0094). The Accenture SCA<br \/>\nPartners Committee may, and upon the written application of the holders of not less than 10%, in the aggregate, of the votes represented by the Employee Covered Shares shall, hold a vote of the Employee Covered Shares to terminate this Agreement. If<br \/>\nthis Agreement is terminated prior to the expiration or termination of the Transfer Restrictions referred to in Section 2.1, such restrictions on transfer shall continue to apply in accordance with the provisions of such Section unless waived or<br \/>\nterminated as provided in paragraph (b) or (e) of Section 5.3. <\/font><\/p>\n<p><font size=\"2\">     Not less than once every four years following the IPO Date, the Accenture SCA Partners Committee shall consider whether to propose to the Employee Covered Persons<br \/>\nany amendments to, or the termination of, this Agreement. <\/font><\/p>\n<p><font size=\"2\">     (b) Unless this Agreement is theretofore terminated pursuant to Section 5.1(a) hereof, any Covered Person who ceases to be an employee for any reason other than<br \/>\ndeath shall continue to be bound by all the provisions of this Agreement until such time as such Covered Person holds all Covered Shares free from Transfer Restrictions. Thereafter, such Covered Person shall no longer be bound by the provisions of<br \/>\nthis Agreement other than Sections 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 5.10 and 5.11 (the \u0093Continuing Provisions\u0094), and such Covered Person\u0092s name shall be removed from Appendix A to this<br \/>\nAgreement.<\/font><\/p>\n<p><font size=\"2\">     (c) Unless this Agreement is theretofore terminated pursuant to Section 5.1(a) hereof, the estate of any Covered Person who dies shall from and after the date of<br \/>\nsuch death be bound only by the Continuing Provisions; and such Covered Person\u0092s name shall be removed from Appendix A to this Agreement.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10515c\"><\/a><br \/>\n<u>Section 5.2.\u00a0\u00a0 Amendments<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) Except as provided in Section 4.4 or this Section 5.2, provisions of this Agreement may be amended only by the affirmative vote of 66 2\/3% of the votes<br \/>\nrepresented by the Employee Covered Shares. The Accenture SCA Partners Committee may, and upon the written application of the holders of not less than 10%, in the aggregate, of the votes represented by the Employee Covered Shares shall, hold a vote<br \/>\nof the Employee Covered Shares to amend this Agreement.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (b) In addition to any other vote or approval that may be required under this Section 5.2, any amendment of this paragraph (b), Section 4.2, Section 4.3, paragraph<br \/>\n(e) of Section 5.3 or any other provision the amendment (or addition) of which has the effect of materially changing the rights or obligations of the Accenture SCA Partners Committee hereunder shall require the approval of the Accenture SCA Partners<br \/>\nCommittee.<\/font><\/p>\n<p><font size=\"2\">     (c) In addition to any other vote or approval that may be required under this Section 5.2, any amendment to the Transfer Restrictions that would make such Transfer<br \/>\nRestrictions materially more onerous to a Covered Person will not be enforceable against that Covered Person unless that Covered Person has consented to such amendment.<\/font><\/p>\n<p><font size=\"2\">     (d) In addition to any other vote or approval that may be required under this Section 5.2, any amendment of this Agreement that has the effect of changing the<br \/>\nobligations of Accenture SCA hereunder to make such obligations materially more onerous to Accenture SCA shall require the approval of Accenture SCA.<\/font><\/p>\n<p><font size=\"2\">     (e) In addition to any other vote or approval that may be required under this Section 5.2, any amendment that has the effect of amending the provisions of Section<br \/>\n2.1, Section 2.3 or Section 4.1 shall require the approval of Accenture SCA.<\/font><\/p>\n<p><font size=\"2\">     (f) Each party hereto understands that from time to time certain other persons may become Covered Persons and certain Covered Persons will cease to be bound by the<br \/>\nprovisions of this Agreement pursuant to the terms hereof. Accordingly, this Agreement may be amended by action of the Accenture SCA Partners Committee from time to time and without the approval of any other person, but solely for the purposes of<br \/>\n(i) adding to Appendix A such persons as shall be made party to this Agreement pursuant to the terms hereof and (ii) removing from Appendix A such persons as shall cease to be bound by the provisions of this Agreement pursuant to Sections 5.1(b) or<br \/>\n(c) hereof, which additions and removals shall be given effect from time to time by appropriate changes to Appendix A.<\/font><\/p>\n<p><font size=\"2\">     (g) Any amendment to this Agreement approved in accordance with the terms hereof by the Employee Covered Persons as of an applicable record date shall be binding<br \/>\nupon all persons who subsequently become a party hereto.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10516\"><\/a><br \/>\nSection 5.3.\u00a0\u00a0<u>Waivers.<\/u><\/font><\/p>\n<p><font size=\"2\">     (a) Except as provided in this Section 5.3, provisions of this Agreement may be waived only by the affirmative vote of 66 2\/3% of the votes represented by the<br \/>\noutstanding Employee Covered Shares. The Accenture SCA Partners Committee may, and upon the written application of the holders of not less than 10%, in the aggregate, of the votes represented by the Employee Covered Shares shall, hold a vote to<br \/>\nwaive certain provisions of this Agreement.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (b) In addition to any other action that may be required under paragraph (a) of this Section, any waiver that has the effect of waiving the provisions of Section<br \/>\n2.1 or Section 2.3 shall require the approval of Accenture SCA.<\/font><\/p>\n<p><font size=\"2\">     (c) In addition to any other vote or approval that may be required under this Section 5.3, any waiver of this paragraph (c), Section 4.2, Section 4.3, paragraph (e)<br \/>\nof this Section 5.3 or any other provision the waiver (or alteration) of which has the effect of materially changing the rights or obligations of the Accenture SCA Partners Committee hereunder shall require the approval of the Accenture SCA Partners<br \/>\nCommittee.<\/font><\/p>\n<p><font size=\"2\">     (d) In addition to any other vote or approval that may be required under this Section 5.3, any waiver of this Agreement that has the effect of changing the<br \/>\nobligations of Accenture SCA hereunder to make such obligations materially more onerous to Accenture SCA shall require the approval of Accenture SCA.<\/font><\/p>\n<p><font size=\"2\">     (e) Notwithstanding the foregoing, the Accenture SCA Partners Committee may waive the Transfer Restrictions and the other provisions of this Agreement to permit (A)<br \/>\nCovered Persons to participate as sellers in underwritten public offerings of, and share repurchase programs and tender offers by the Company for, Common Shares; (B) Transfers of Covered Shares to organizations described in Section 501(c)(3) of the<br \/>\nCode, including gifts to \u0093private foundations\u0094 subject to the requirements of Section 509 of the Code or comparable provisions of the laws of other countries; (C) Transfers of Covered Shares held in employee benefit plans of the Company<br \/>\neither generally or in particular situations; and (D) particular Covered Persons, a particular class of Covered Persons or all Covered Persons to Transfer Covered Shares in particular situations (such as Transfers to family members, partnerships or<br \/>\ntrusts), but not generally; provided that in each of (A) through (D), waivers of the restrictions imposed by Section 2.3 shall also require the prior written consent of the Company.<\/font><\/p>\n<p><font size=\"2\">     (f) In connection with any waiver granted under this Agreement, the Accenture SCA Partners Committee or the Employee Covered Persons proposing the waiver pursuant<br \/>\nto this Section 5.3, as the case may be, may impose such conditions as they determine on the granting of such waivers.<\/font><\/p>\n<p><font size=\"2\">     (g) The failure of Accenture SCA or the Accenture SCA Partners Committee at any time or times to require performance of any provision of this Agreement shall in no<br \/>\nmanner affect the rights at a later time to enforce the same. No waiver by Accenture SCA or the Accenture SCA Partners Committee of the breach of any term contained in this Agreement, whether by conduct or otherwise, in any one or more instances,<br \/>\nshall be deemed to be or construed as a further or continuing waiver of any such breach or the breach of any other term of this Agreement.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10517\"><\/a><br \/>\nSection 5.4.   <u>GOVERNING LAW<\/u>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF LUXEMBOURG.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10517a\"><\/a><br \/>\nSection 5.5.\u00a0\u00a0 <u>Resolution of Disputes<\/u>.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (a) The Accenture SCA Partners Committee shall have the sole and exclusive power to enforce the provisions of this Agreement. The Accenture SCA Partners Committee<br \/>\nmay in their sole discretion direct Accenture SCA to pursue such enforcement, and Accenture SCA agrees to pursue such enforcement as directed by the Accenture SCA Partners Committee. <\/font><\/p>\n<p><font size=\"2\">     (b) Any and all disputes which cannot be settled amicably, including any ancillary claims of any party, arising out of, relating to or in connection with the<br \/>\nvalidity, negotiation, execution, interpretation, performance or non-performance of this Agreement (including the validity, scope and enforceability of this arbitration provision) shall be finally settled by arbitration conducted by a single<br \/>\narbitrator in New York in accordance with the then-existing Rules of Arbitration of the International Chamber of Commerce, except that the parties may select an arbitrator who is a national of the same country as one of the parties. If the parties<br \/>\nto the dispute fail to agree on the selection of an arbitrator within thirty (30) days of the receipt of the request for arbitration, the International Chamber of Commerce shall make the appointment. The arbitrator shall be a lawyer and shall<br \/>\nconduct the proceedings in the English language. <\/font><\/p>\n<p><font size=\"2\">     Performance under this Agreement shall continue if reasonably possible during any arbitration proceedings.<\/font><\/p>\n<p><font size=\"2\">     (c) Notwithstanding the provisions of paragraph (b), the Accenture SCA Partners Committee may bring, or may cause Accenture SCA to bring, on behalf of the Accenture<br \/>\nSCA Partners Committee or on behalf of one or more Covered Persons, an action or special proceeding in any court of competent jurisdiction for the purpose of compelling a party to arbitrate, seeking temporary or preliminary relief in aid of an<br \/>\narbitration hereunder, and\/or enforcing an arbitration award and, for the purposes of this paragraph (c), each Covered Person (i) expressly consents to the application of paragraph (d) of this Section 5.5 to any such action or proceeding, (ii)<br \/>\nagrees that proof shall not be required that monetary damages for breach of the provisions of this Agreement would be difficult to calculate and that remedies at law would be inadequate, and (iii) irrevocably appoints the General Partner of<br \/>\nAccenture SCA 398 Route d\u0092Esch, L-1471, Luxembourg (or, if different, the then-current corporate seat of Accenture SCA) as such Covered Person\u0092s agent for service of process in connection with any such action or proceeding and agrees that<br \/>\nservice of process upon such agent, who shall promptly advise such Covered Person of any such service of process, shall be deemed in every respect effective service of process upon the Covered Person in any such action or proceeding.<\/font><\/p>\n<p><font size=\"2\">     (d) (i) EACH COVERED PERSON HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF COURTS LOCATED IN NEW YORK, UNITED STATES FOR THE PURPOSE OF ANY JUDICIAL PROCEEDING<br \/>\nBROUGHT IN ACCORDANCE WITH THE PROVISIONS OF PARAGRAPH (C) OF THIS SECTION 5.5, OR ANY JUDICIAL PROCEEDING ANCILLARY TO AN ARBITRATION OR CONTEMPLATED ARBITRATION ARISING OUT OF OR RELATING TO OR CONCERNING THIS AGREEMENT. Such ancillary judicial<br \/>\nproceedings include any suit, action or proceeding to compel arbitration, to obtain temporary or preliminary judicial relief in aid of arbitration, or to confirm an arbitration award. The parties acknowledge that the fora designated by this<br \/>\nparagraph (d) have a reasonable relation to this Agreement, and to the parties\u0092 relationship with one another. <\/font><\/p>\n<\/p>\n<p><font size=\"2\">     (ii) The parties hereby waive, to the fullest extent permitted by applicable law, any objection which they now or hereafter may have to personal jurisdiction or to<br \/>\nthe laying of venue of any such ancillary suit, action or proceeding brought in any court referred to in paragraph (d)(i) of this Section 5.5 and such parties agree not to plead or claim the same. <\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10519\"><\/a><br \/>\nSection 5.6.  <u>Relationship of Parties<\/u>. The terms of this Agreement are not intended to create a separate entity for United States federal or state income tax purposes or under the laws of any other jurisdiction. Nothing in this Agreement<br \/>\nshall be read to create any partnership, joint venture or separate entity among the parties or to create any trust or other fiduciary relationship between them.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10519a\"><\/a><br \/>\nSection 5.7.\u00a0\u00a0<u>Notices<\/u>.<\/font><\/p>\n<p><font size=\"2\">     (a) Any communication, demand or notice to be given hereunder will be duly given (and shall be deemed to be received) when delivered in writing by hand or first<br \/>\nclass mail or by telecopy to a party at its address as indicated below:<\/font><\/p>\n<p><font size=\"2\">If to a Covered Person,<\/font><\/p>\n<ul>\n<ul>\n<ul>\n<p><font size=\"2\">c\/o Accenture SCA<br \/>\n<br \/>\n398 Route d\u0092Esch<br \/>\n<br \/>\nL-1471<br \/>\n<br \/>\nLuxembourg<br \/>\n<br \/>\nTelecopy: (352) 48 18 28 3419<br \/>\n<br \/>\nAttention: General Partner<br \/>\n<br \/>\n(or, if different, the then-current corporate seat of Accenture SCA)<\/font><\/p>\n<\/ul>\n<\/ul>\n<\/ul>\n<p><font size=\"2\">If to the Accenture SCA Partners Committee, <\/font><\/p>\n<ul>\n<ul>\n<ul>\n<p><font size=\"2\">c\/o Accenture SCA<br \/>\n<br \/>\n398 Route d\u0092Esch<br \/>\n<br \/>\nL-1471<br \/>\n<br \/>\nLuxembourg<br \/>\n<br \/>\nTelecopy: (352) 48 18 28 3419<br \/>\n<br \/>\nAttention: General Partner<br \/>\n<br \/>\n(or, if different, the then-current corporate seat of Accenture SCA)<\/font><\/p>\n<\/ul>\n<\/ul>\n<\/ul>\n<p><font size=\"2\">and<\/font><\/p>\n<p><font size=\"2\">If to Accenture SCA,<\/font><\/p>\n<ul>\n<ul>\n<ul>\n<p><font size=\"2\">398 Route d\u0092Esch<br \/>\n<br \/>\nL-1471<br \/>\n<br \/>\nLuxembourg<br \/>\n<br \/>\nTelecopy: (352) 48 18 28 3419<br \/>\n<br \/>\nAttention: General Partner<br \/>\n<br \/>\n(or, if different, the then-current corporate seat of Accenture SCA)<\/font><\/p>\n<\/ul>\n<\/ul>\n<\/ul>\n<p><font size=\"2\">     Accenture SCA shall be responsible for notifying each Covered Person of the receipt of a communication, demand or notice under this Agreement relevant to such<br \/>\nCovered Person, in writing, at the address of such Covered Person then in the records of Accenture SCA (and each Covered Person shall notify Accenture SCA of any change in such address for communications, demands and notices) or by electronic mail<br \/>\nto the principal electronic address of such person maintained by the Company.<\/font><\/p>\n<p><font size=\"2\">     (b) Unless otherwise provided to the contrary herein, any notice which is required to be given in writing pursuant to the terms of this Agreement may be given by<br \/>\ntelecopy. <\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10520\"><\/a><br \/>\nSection 5.8.  <u>Severability<\/u>.  If any provision of this Agreement is finally held to be invalid, illegal or unenforceable, the remaining terms and provisions hereof shall be unimpaired. <\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10520a\"><\/a><br \/>\nSection 5.9.  <u>Right to Determine Tender Confidentially<\/u>. In connection with any tender or exchange offer for all or any portion of the outstanding Common Shares, subject to compliance with all applicable restrictions on Transfer in this<br \/>\nAgreement or any other agreement with the Company, each Covered Person shall have the right to determine confidentially whether such Covered Person\u0092s Covered Shares will be tendered in such tender or exchange offer.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10520b\"><\/a><br \/>\nSection 5.10.  <u>No Third-Party Rights<\/u>. Nothing expressed or referred to in this Agreement will be construed to give any person other than the parties to this Agreement any legal or equitable right, remedy, or claim under or with<br \/>\nrespect to this Agreement or any provision of this Agreement. This Agreement and all of its provisions and conditions are for the sole and exclusive benefit of the parties to this Agreement and their successors and permitted assigns.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10520c\"><\/a><br \/>\nSection 5.11.  <u>Section Headings<\/u>. The headings of sections in this Agreement are provided for convenience only and will not affect its construction or interpretation.<\/font><\/p>\n<p><font size=\"2\"><br \/>\n<a name=\"486ex10520d\"><\/a><br \/>\nSection 5.12.  <u>Execution in Counterparts<\/u>. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one agreement.<\/font><\/p>\n<\/p>\n<p><font size=\"2\">     IN WITNESS WHEREOF, the parties hereto have duly executed or caused to be duly executed this Transfer Rights Agreement as of the date first above written.<\/font><\/p>\n<ul>\n<ul>\n<ul>\n<ul>\n<ul>\n<ul>\n<p><font size=\"2\">     ACCENTURE SCA<br \/>\n<br \/>\n     By: ACCENTURE LTD, its General Partner<\/font><\/p>\n<p><font size=\"2\"><\/p>\n<p>     By _________________________________<br \/>\n<br \/>\n           Name:<br \/>\n<br \/>\n           Title:<\/font><\/p>\n<\/p>\n<\/ul>\n<\/ul>\n<\/ul>\n<\/ul>\n<\/ul>\n<\/ul>\n<p align=\"CENTER\"><font size=\"2\">[Signature blocks of Covered Persons set forth separately.]<\/font><\/p>\n<\/p>\n<p align=\"RIGHT\"><font size=\"2\"><br \/>\n<a name=\"486ex10523\"><\/a><br \/>\nAPPENDIX A<\/font><\/p>\n<p align=\"CENTER\"><font size=\"2\"><u>Covered Persons<\/u><\/font><\/p>\n<\/blockquote>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6553],"corporate_contracts_industries":[9505],"corporate_contracts_types":[9573,9577],"class_list":["post-41664","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-accenture-ltd","corporate_contracts_industries-services__management","corporate_contracts_types-formation","corporate_contracts_types-formation__partner"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/41664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=41664"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=41664"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=41664"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=41664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}